www.axisresearchmind.

com | Copyright 2014 | All Rights Reserved

CARDIAC RESYNCHRONIZATION
THERAPY (CRT) DEVICES
BRICSS TRENDS, ESTIMATES AND FORECASTS, 2012-2018
PRICE: US$2500
NO. OF PAGES: 476
TABLES/CHARTS: 103
REPORT CODE: ARMMR141N.1
PUBLICATION: JUNE 2014
www.axisresearchmind.com | Copyright 2014 | All Rights Reserved

For more information on this report publication, please reach us at:
sales@axisresearchmind.com 2
CARDIAC RESYNCHRONIZATION THERAPY (CRT)
DEVICES
BRICSS TRENDS, ESTIMATES AND FORECASTS, 2012-2018
SEGMENTATION - By TYPE
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
CARDIAC RESYNCHRONIZATION PACEMAKERS (CRT-P)
CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES -
BRICSS MARKET WATCH, 2012-2018
BRICSS Cardiac Resynchronization Therapy (CRT) Devices market value is expected to reach
US$455 million by 2016, primarily supported by the product types - Cardiac Resynchronization
Therapy Defibrillator (CRT-D) and Cardiac Resynchronization Pacemakers (CRT-P). China
accounts for nearly 25% of the market share and
India claims more than 23%. In terms of CAGR, China
is the fastest growing region while India and South
Korea are just behind. Among the product types,
Cardiac Resynchronization Therapy Defibrillator (CRT-D) accounts more nearly half of the
market value while Cardiac Resynchronization Pacemakers (CRT-P) segments add up to the
remaining half.
Healthcare Industry division has been witnessing a drastic change regarding the new innovation
and technology which in terms are applied in improving from sector to sector since the past 3-5
years. Cardiovascular industry growth continues to increase with the presence of multiple
technologies such as advanced material and software which is featured in most of the devices.
International companies tends to innovate, develop new products and to enhance the existing
features in cardiovascular devices.
BRICSS CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES -
MARKET SHARE BY TYPE - 2015-%
Getting the Most from Our Research
Analysis
www.axisresearchmind.com | Copyright 2014 | All Rights Reserved

For more information on this report publication, please reach us at:
sales@axisresearchmind.com 3
CARDIAC RESYNCHRONIZATION THERAPY (CRT)
DEVICES
BRICSS TRENDS, ESTIMATES AND FORECASTS, 2012-2018
REPORT FOCUS
The report Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets
(Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 reviews
the latest trends in cardiovascular devices with a perceptive attempt to disclose the
near-future growth prospects. An in-depth analysis on a geographic basis provides
strategic business intelligence for healthcare sector investments. The study reveals
profitable investment strategies for market start-ups, pharmaceutical/biotechnology
companies, laboratories, Contract/Clinical/Commercial Research Organizations
(CROs), government/academic organizations, consulting firms, database buyers and
many more in preferred locations.
The report focuses on the current market trends, estimates and forecasts for the
period 2012-2018. More than 727 market players are identified in cardiovascular
devices industry out of which 122 key
companies that project improved market
activities in the near future are profiled. The
report consists of 103 data charts describing
the market shares, sales forecasts and growth prospects. Moreover, key strategic
activities in the market including mergers/acquisitions, collaborations/partnerships,
product launches/developments are discussed which gives a deep insight into the
growth perspectives of the market.
Estimates are based on online surveys using customized questionnaires by our research
team. Besides information from government databases, company websites, press
releases & published research reports are also used for estimates.
KEY COMPANIES PROFILED
ABBOTT VASCULAR DEVICES, ACCELLENT, INC., AEROTEL MEDICAL SYSTEMS, LTD.,
ANGIODYNAMICS, INC., ASAHI INTECC CO., LTD., ASAHI KASEI CORPORATION, BERLIN
HEART GMBH, BIOHEART, INC., BIOSENSORS INTERNATIONAL GROUP, LTD., BIOTRONIK
GMBH & CO. KG., BOSTON SCIENTIFIC CORPORATION, C. R. BARD, INC., CAMBRIDGE
HEART, INC., CARDIOCOMM SOLUTIONS, INC., CARDIOROBOTICS, INC., COOK GROUP
INCORPORATED, DRGER MEDICAL AG & CO. KG, ESAOTE S.P.A, FUDAN UNIVERSITY
ZHONGSHAN HOSPITAL, GE HEALTHCARE, HEARTWARE LTD., INDRAPRASTHA APOLLO
HOSPITAL, ITGI MEDICAL LTD., MEDTRONIC, INC., MERIT MEDICAL SYSTEMS, INC.,
MOLECULAR DEVICES, LLC, NIHON KOHDEN CORPORATION, SAHAJANAND MEDICAL
TECHNOLOGIES PVT.,LTD., SORIN GROUP USA, INC., SPECTRANETICS INTERNATIONAL
B.V, ST. JUDE MEDICAL, USCOME LIMITED and many more
Learn High Potential Market Dynamics
for Strategic Business Planning
www.axisresearchmind.com | Copyright 2014 | All Rights Reserved

For more information on this report publication, please reach us at:
sales@axisresearchmind.com 4
CARDIAC RESYNCHRONIZATION THERAPY (CRT)
DEVICES
BRICSS TRENDS, ESTIMATES AND FORECASTS, 2012-2018
GEOGRAPHIC COVERAGE
The region-wise distribution consists of Emerging Markets (Brazil, Russia, India,
China, South Africa And South Korea) analyzed individually.
TO PURCHASE THIS REPORT, FOLLOW BELOW LINK:
Cardiac Resynchronization Therapy (CRT) Devices - Emerging
Markets (Brazil, Russia, India, China, South Africa And South
Korea), 2012-2018